Despite increased investments by Lilly and Novo to boost production, shortages continue, especially for the lower starter doses of Wegovy, which the FDA still lists as being in shortage
Inform patients on the symptoms of hypersensitivity reactions [see Warnings and Precautions (5.5)]
Propensity-score matching (PSM) at a 1:3 ratio between GLP1RA and DPP4i groups was done to minimise possible selection bias
However, in 2001, a handful of groundbreaking research discoveries confirmed that the Ca 2+ ionophore ionomycin could trigger an apoptosis-like cell death in erythrocytes associated with the appearance of apoptotic signs, including cell shrinkage, membrane vesiculation, or PS exposure [22, 23]
In clinical trials, patients lost 1522% of body weight, outperforming even semaglutide